NUCRYST Pharmaceuticals Corp. (USA) (NASDAQ:NCST)
CAPS Rating:
The Company develops, manufactures and commercializes innovative medical products that fight infection and inflammation.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| SteadySaber | 76.58 | 7/23/2007 |
|
5Y | $1.08 | +64.33% | -9.93% | -74.26 | 0 Comment | |
| akalordx | 94.58 | 7/23/2007 |
|
NS | $1.09 | +61.95% | -10.06% | +72.02 | 0 Comment | |
| stevesliva | 94.71 | 11/10/2006 |
|
5Y | $1.44 | +23.28% | +1.50% | +21.78 | 1 Comment | |
| jwolfe5 | < 20 | 11/9/2006 |
|
3M | $1.43 | +23.49% | +0.85% | +22.64 | 1 Comment | |
| mikeyuww | 23.87 | 10/26/2006 |
|
NS | $1.36 | +30.43% | +0.85% | +29.58 | 0 Comment | |
| TMFNosediveflip | 61.23 | 9/22/2006 |
|
1Y | $1.96 | -9.78% | +6.51% | +16.30 | 0 Comment | |
| bassin604 | 60.27 | 9/22/2006 |
|
3M | $1.94 | -8.79% | +6.31% | -15.09 | 0 Comment | |
| Braema | < 20 | 8/23/2006 |
|
1Y | $3.21 | -44.93% | +8.63% | -53.57 | 1 Comment |
RSS Headlines
Fool UK
- Active (8)
-
Ended (13)
-
All (21)
Results 1 - 8 of 8